• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: severe COVID-19 infection and biologic therapies-a cohort study of 7808 patients in France. Authors' reply.

作者信息

Taxonera Carlos, Alba Cristina

机构信息

Inflammatory Bowel Disease Unit, Department of Gastroenterology, Hospital Clínico San Carlos and Instituto de Investigación del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

出版信息

Aliment Pharmacol Ther. 2020 Oct;52(7):1249-1250. doi: 10.1111/apt.16055.

DOI:10.1111/apt.16055
PMID:33016549
Abstract
摘要

相似文献

1
Letter: severe COVID-19 infection and biologic therapies-a cohort study of 7808 patients in France. Authors' reply.
Aliment Pharmacol Ther. 2020 Oct;52(7):1249-1250. doi: 10.1111/apt.16055.
2
Letter: severe COVID-19 infection and biologic therapies-a cohort study of 7 808 patients in France.信函：重症新型冠状病毒肺炎感染与生物疗法——法国7808例患者的队列研究
Aliment Pharmacol Ther. 2020 Oct;52(7):1245-1248. doi: 10.1111/apt.16040.
3
Letter: pregnant women with IBD are more likely to be adherent to biologic therapies than other medications-authors' reply.
Aliment Pharmacol Ther. 2020 May;51(9):916-917. doi: 10.1111/apt.15699.
4
Letter: liver involvement and mortality in COVID-19 patients - authors' reply.信函：新冠病毒感染患者的肝脏受累情况及死亡率——作者回复
Aliment Pharmacol Ther. 2020 Oct;52(7):1264-1265. doi: 10.1111/apt.16052.
5
Letter: elevated liver enzymes and outcomes in COVID Authors' reply.信件：新冠患者中肝酶升高与预后 作者回复
Aliment Pharmacol Ther. 2020 Oct;52(7):1235-1236. doi: 10.1111/apt.16028.
6
Letter: unknown denominator and misleading conclusions in Covid-19-authors' reply.信件：关于新冠疫情中未知分母和误导性结论——作者回复
Aliment Pharmacol Ther. 2020 Oct;52(7):1243-1244. doi: 10.1111/apt.16056.
7
Letter: population mortality from COVID-19 and latitude-data from China. Authors' reply.信函：新冠病毒肺炎导致的人群死亡率与纬度——来自中国的数据。作者回复。
Aliment Pharmacol Ther. 2020 Oct;52(7):1261-1262. doi: 10.1111/apt.16058.
8
Letter: liver disease and COVID-19-not the perfect storm. Authors' reply".信件：肝病与2019冠状病毒病——并非完美风暴。作者回复
Aliment Pharmacol Ther. 2020 Aug;52(3):574-575. doi: 10.1111/apt.15886.
9
Letter: gastrointestinal symptoms pre-admission are associated with greater severity of COVID-19-authors' reply.信件：入院前的胃肠道症状与新冠病毒疾病的更严重程度相关——作者回复
Aliment Pharmacol Ther. 2020 Oct;52(7):1231-1232. doi: 10.1111/apt.16045.
10
Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors. Authors' reply.信函：肠道炎症、COVID-19与胃肠道ACE2——探索RAS抑制剂。作者回复。
Aliment Pharmacol Ther. 2020 Aug;52(3):571-572. doi: 10.1111/apt.15893. Epub 2020 Jun 25.